Incidence of TNS After Intrathecal Lidocaine v.s Bupivacaine

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will look into the incidence of Transient neurological symptoms (TNS) after the intrathecal use of lidocaine in comparison to intrathecal Bupivacaine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: McGill University Health Center; McGill University Health Centre/Research Institute of the McGill University Health Centre
• Treatments: Bupivacaine; Lidocaine

Criteria

Inclusion Criteria:

• ASA I-III male and female patients aged between 18 to 80 years old, who will receive spinal anesthesia for surgeries lasting less than one hour.

Exclusion Criteria:

• Patients younger than 18 years old.

• ASA physical status >3.

• Immunosuppression or high risk of infection.

• Contraindications to receiving spinal anesthesia (e.g. coagulation impairment).

• Patients with psychosis

• Patients with preexisting back pain.

• Patients with cognitive impairment

• Allergies to local anesthetics, analgesics or any medication used in the study.

• Patients with chronic regular opioid usage

• Presence of preexisting neurological symptoms.